Company Search:
Advanced Search
Sponsored Links
Arcus Biosciences Inc Company Snapshot
Arcus Biosciences Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arcus Biosciences Inc with three other companies in this sector in UNITED STATES : Surface Oncology Inc (2019 sales of $15.36 million of which 100% was Pharmaceutical), Five Prime Therapeutics Inc ($14.87 million of which 100% was Clinical-stage biotechnology), and Ascendis Pharma A/S ($14.95 million of which 74% was Revenue from rendering of services(Recog).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Arcus Biosciences Inc
  Stock Performance Chart for Arcus Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/29/2020): 31.35
(Figures in U.S. Dollars)
1 Week -12.4%   13 Weeks 19.6%  
4 Weeks 106.0%   52 Weeks 269.7%  
Arcus Biosciences Inc Key Data:
  Ticker: RCUS Country: United States
  Exchanges: NYSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 15,000,000
(Year Ending Jan 2020).
Employees: 139
  Currency: U.S. Dollars Market Cap: 1,439,748,875
  Fiscal Yr Ends: December Shares Outstanding: 45,925,004
  Share Type: Common Closely Held Shares: 13,339,064
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.